|
|
Article: Advanced BioHealing Announces First Diabetes Patient Adherence Program for Foot Ulcer Treatment.
- Article from:
- Business Wire
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Heal2gether Partnership Program Demonstrates Continued Leadership and Commitment to Improving Patient Outcomes
WESTPORT, Conn. -- Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine and the maker of Dermagraft[R], launched during American Diabetes Month the Heal2gether Partnership Program for diabetes patients and their physicians. Focused on patient adherence, Heal2gether aims to increase awareness and proper care of diabetic foot ulcers (DFUs), enhance the effective use of living cell technologies in treating DFUs, and encourage patients to take an active role in their healing process.
"Treatment of ...
Related newspaper, magazine, and journal articles:
|
|
Article: Advanced BioHealing and Regenesis Biomedical Form ...
PR Newswire;
May 7, 2008 ;
700+ words
... ... Ariz., May 7 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH) and Regenesis Biomedical ... Kevin Rakin, Chairman and CEO of Advanced BioHealing. "The management team at Regenesis ... regenesisbiomedical.com/ About Advanced BioHealing, Inc. Advanced BioHealing is an ...
|
|